Menu
Back to User profile » Dr Yu-Hung Fang
Papers published by Dr Yu-Hung Fang:
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer
Chung YS, Lin YC, Hung MS, Ho MC, Fang YH
OncoTargets and Therapy 2022, 15:1563-1571
Published Date: 28 December 2022
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
Ho MC, Chung YS, Lin YC, Hung MS, Fang YH
OncoTargets and Therapy 2022, 15:1573-1582
Published Date: 28 December 2022
Sleep Quality and Related Factors in Patients with Breast Cancer: A Cross-Sectional Study in Taiwan
Weng YP, Hong RM, Chen VCH, Tsai CJ, Yeh DC, Fang YH
Cancer Management and Research 2021, 13:4725-4733
Published Date: 14 June 2021
Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy
Fang YH, Hsieh MJ, Hung MS, Lin YC, Kuo LT, Lu ML, Tzang BS, Chen VCH
Neuropsychiatric Disease and Treatment 2020, 16:2103-2109
Published Date: 17 September 2020
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
Fang YH, Yang YH, Hsieh MJ, Hung MS, Lin YC
Cancer Management and Research 2019, 11:8539-8546
Published Date: 19 September 2019
Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer
Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC
OncoTargets and Therapy 2017, 10:5173-5177
Published Date: 25 October 2017